MarketFrame

FTSE 100 news / Companies and sectors / Pharma and healthcare / 4 October 2026

Pharma and healthcare: sector news on Sunday 4 October 2026

Average tone +3.6 (positive) across 4 companies with relevant coverage, from 9 stories.

Company by company

CompanyToneStoriesWhat the coverage was about
AstraZeneca+3.74Coverage mostly centred on AstraZeneca's tie-up with Summit Therapeutics and Daiichi Sankyo to test a cancer drug combination, which leans positive.
Haleon+1.82Coverage was limited to the appointment of Vandana Chamaria as Head of Oral Health, South Asia.
Smith & Nephew+2.02Coverage was light, with a trading-pattern note on the shares and a share price update alongside a showcase of its shoulder technologies.
GSK+7.01Coverage centred on GSK agreeing to acquire the ChImagen therapy for $750 million.
Convatec–0

Strongest stories in the sector

Pharma and healthcare: every day · FTSE 100 overview for the day